Agile Therapeutics Inc (AGRX)
0.4048
-0.03
(-7.90%)
USD |
OTCM |
May 02, 15:56
Agile Therapeutics Free Cash Flow: -9.577M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.577M |
| September 30, 2023 | -11.31M |
| June 30, 2023 | -28.38M |
| March 31, 2023 | -22.79M |
| December 31, 2022 | -36.08M |
| September 30, 2022 | -51.19M |
| June 30, 2022 | -53.14M |
| March 31, 2022 | -65.61M |
| December 31, 2021 | -65.47M |
| September 30, 2021 | -81.59M |
| June 30, 2021 | -62.95M |
| March 31, 2021 | -54.36M |
| December 31, 2020 | -47.66M |
| September 30, 2020 | -18.21M |
| June 30, 2020 | -23.32M |
| March 31, 2020 | -18.87M |
| December 31, 2019 | -15.79M |
| September 30, 2019 | -15.58M |
| June 30, 2019 | -14.33M |
| March 31, 2019 | -16.18M |
| December 31, 2018 | -17.21M |
| Date | Value |
|---|---|
| September 30, 2018 | -20.43M |
| June 30, 2018 | -23.73M |
| March 31, 2018 | -25.85M |
| December 31, 2017 | -25.87M |
| September 30, 2017 | -22.45M |
| June 30, 2017 | -22.68M |
| March 31, 2017 | -22.60M |
| December 31, 2016 | -23.33M |
| September 30, 2016 | -25.48M |
| June 30, 2016 | -25.32M |
| March 31, 2016 | -26.67M |
| December 31, 2015 | -25.77M |
| September 30, 2015 | -26.26M |
| June 30, 2015 | -26.85M |
| March 31, 2015 | -21.36M |
| December 31, 2014 | -14.60M |
| September 30, 2014 | -10.93M |
| June 30, 2014 | -7.362M |
| March 31, 2014 | -9.769M |
| December 31, 2013 | -17.96M |
Free Cash Flow Range, Past 5 Years
-81.59M
Minimum
Sep 2021
-9.577M
Maximum
Dec 2023
-36.64M
Average
-28.38M
Median
Jun 2023
Free Cash Flow Benchmarks
| Altimmune Inc | -75.86M |
| iBio Inc | -18.89M |
| Verastem Inc | -86.46M |
| Oragenics Inc | -7.291M |
| Actinium Pharmaceuticals Inc | -39.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 0.172M |
| Cash from Financing (Quarterly) | -0.487M |
| Free Cash Flow Per Share (Quarterly) | 0.0579 |
| Free Cash Flow to Equity (Quarterly) | 0.434M |
| Free Cash Flow to Firm (Quarterly) | 0.46M |
| Free Cash Flow Yield | -1.10K% |